St. Francis Cancer Center | St. Francis Cancer Center | AEWS1221
st francis cancer center, cancer center greenville sc, cancer care greenville sc, aya cancer care, aya cancer care greenville sc
1651
clinical-trial-template-default,single,single-clinical-trial,postid-1651,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-3.7,wpb-js-composer js-comp-ver-4.12,vc_responsive

Clinical Trials

AEWS1221

AEWS1221 – Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008, IND# 120449) to Multiagent Chemotherapy for Patients with Newly Diagnosed Metastatic Ewing Sarcoma… read more>

« Available Clinical Trials